Who Owns Chemomab Therapeutics Stock?
NASDAQ: CMMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:57 AM ET
Ownership breakdown
- Held by institutions
- 19.07%
- Held by insiders
- 12.19%
- Institutional holders
- 15
- Institutions 19.1%
- Insiders 12.2%
- Public and other 68.7%
Who owns Chemomab Therapeutics stock?
Institutional investors own about 19.1% of Chemomab Therapeutics's shares, spread across 15 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 12.19% of CMMB.
The largest institutional holders are Citadel Advisors Llc (1.32%), Adar1 Capital Management, LLC (1.10%) and Kestra Private Wealth Services, LLC (0.85%). Together, the top 10 institutions control 5.2% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CMMB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CMMB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Citadel Advisors Llc | 95.31K | 1.32% | +48.5% |
| Adar1 Capital Management, LLC | 80.00K | 1.10% | 0.0% |
| Kestra Private Wealth Services, LLC | 61.71K | 0.85% | 0.0% |
| Ikarian Capital, LLC | 51.79K | 0.71% | 0.0% |
| Rhumbline Advisers | 30.53K | 0.42% | +66.2% |
| Xtx Topco Ltd | 15.99K | 0.22% | -14.2% |
| Philadelphia Investment Partners, LLC | 15.00K | 0.21% | +82.9% |
| Lido Advisors, LLC | 14.34K | 0.20% | +100.0% |
| BNP Paribas Financial Markets | 6.80K | 0.09% | -19.2% |
| Gamma Investing LLC | 4.74K | 0.07% | -37.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CMMB
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 5.56K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Chemomab Therapeutics?
Citadel Advisors Llc is the largest institutional shareholder of CMMB, owning 1.32% of shares outstanding (95.31K shares) as of its latest 13F filing.
What percentage of Chemomab Therapeutics is owned by institutions?
Institutions own about 19.1% of CMMB shares and 21.7% of the public float.
How much of Chemomab Therapeutics do insiders own?
Insiders, such as officers and directors, own about 12.19% of CMMB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.